Article Versions Notes

Heredero J, Peña Á, Broset E, Blandín B, de Miguel D, Alejo T, Toro A, Mata E, López-Gavín A, Gallego-Lleyda A, et al. Predictive Lung- and Spleen-Targeted mRNA Delivery with Biodegradable Ionizable Lipids in Four-Component LNPs. Pharmaceutics. 2025; 17(4):459. https://doi.org/10.3390/pharmaceutics17040459

Heredero, Juan, Álvaro Peña, Esther Broset, Beatriz Blandín, Diego de Miguel, Teresa Alejo, Alfonso Toro, Elena Mata, Alexandre López-Gavín, Ana Gallego-Lleyda, and et al. 2025. "Predictive Lung- and Spleen-Targeted mRNA Delivery with Biodegradable Ionizable Lipids in Four-Component LNPs" Pharmaceutics 17, no. 4: 459. https://doi.org/10.3390/pharmaceutics17040459

Heredero, J., Peña, Á., Broset, E., Blandín, B., de Miguel, D., Alejo, T., Toro, A., Mata, E., López-Gavín, A., Gallego-Lleyda, A., Casabona, D., Lampaya, V., Larraga, A., Pérez-Herrán, E., Luna, D., Orera, I., Romanos, E., García, A., Martínez-Oliván, J., & Giménez-Warren, J. (2025). Predictive Lung- and Spleen-Targeted mRNA Delivery with Biodegradable Ionizable Lipids in Four-Component LNPs. Pharmaceutics, 17(4), 459. https://doi.org/10.3390/pharmaceutics17040459